|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
MGI PHARMA, INC. (MOGN) Release: Notice of Correction to Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024
1/8/2008 9:28:21 AM
BLOOMINGTON, Minn.--(BUSINESS WIRE)--On December 26, 2007, MGI PHARMA, INC. issued a Notice of Conversion Right to holders of its Senior Subordinated Convertible Notes due 2024. The notice incorrectly listed February 15, 2007 as the date after which any note surrendered for conversion would also be entitled to payment of interest on the note otherwise due on March 3, 2008. The correct date is February 15, 2008. The full text of the notice, as corrected, is set forth below.
|
|
|
|
|
|
|
|
|
|
|